Improved antisaccade performance with risperidone in schizophrenia

Journal of Neurology Neurosurgery and Psychiatry

Volumn 72, Issue 4, 2002, Pages 449-454

  Burke, J G ^a   Reveley, M A ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOPENTHIXOL; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; RISPERIDONE; SULPIRIDE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; EYE POSITION; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SCHIZOPHRENIA; TASK PERFORMANCE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; RISPERIDONE; SACCADES; SCHIZOPHRENIA; TASK PERFORMANCE AND ANALYSIS; TREATMENT OUTCOME;

EID: 0036219429     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.72.4.449     Document Type: Article

References (28)

1. A pathophysiological approach to saccadic eye movements in neurological and psychiatric disease
2. Saccadic abnormalities in psychotic patients I. Neuroleptic-free psychotic patients
3. Oculomotor abnormalities in schizophrenia: A critical review
4. Further analysis of the control of voluntary saccadic eye movements in schizophrenic patients
5. Cortical control of saccades in normal and schizophrenic subjects: A PET study using a task-evoked rCBF paradigm
6. Functional neuroanatomy of antisaccade eye movements investigated with positron emission tomography
7. Increased saccadic distractability in tardive dyskinesia, functional evidence for subcortial GABA dysfunction
8. Neuropsychology of eye movement abnormalities in schizophrenia
9. Saccadic eye movement abnormalities in schizophrenic patients treated with clozapine, risperidone or sulpiride
10. Smooth pursuit and saccadic abnormalities in first-episode schizophrenia
11. Correlation between antisaccade and Wisconsin card sorting test performance in schizophrenia
12. Voluntary control of saccadic eye movement in patients with frontal cortical lesions and Parkinsonian patients in comparison with that in schizophrenics
13. Saccadic and attentional abnormalities in patients with schizophrenia
14. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone
15. Risperidone in the treatment of schizophrenia
16. The relationship of pharmacology to side effects
17. Cognitive dysfunction in schizophrenia: Comparison of treatment of atypical antipsychotic agents and conventional antipsychotic drugs
18. Does risperidone improve verbal working memory in treatment-resistant schizophrenia
19. Risperidone, negative symptoms and cognitive deficit in schizophrenia an open study
20. The effects of risperidone on attention and motor function in schizophrenia
21. The effects of risperidone on verbal fluency and executive function in schizophrenia
22. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
23. Central nervous system effects of ingestions of L-tryptophan by normal subjects
24. Reduction of the central effects of tryptophan by a decarboxylase inhibitor
25. Myoclonus and ocular oscillations induced by L-tryptophan
26. Adverse effects of risperidone on eye movement activity: A comparison of risperidone and haloperidol in antipsychotic-naïve schizophrenic patients